NCT01324752View on ClinicalTrials.gov

A Drug-Drug Interaction Study of Losartan and PA21

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Drug Interaction Potentiation
Interventions
DRUG

PA21 and Losartan with Food

The maximum dose of PA21 will be 15.0 g/day. The maximum dose of Losartan will be 100 mg/day.

DRUG

No PA21; Losartan with food

The maximum dose of Losartan will be 100 mg/day.

DRUG

PA21 with food and Losartan 2 hours later

The maximum dose of PA21 will be 15.0 g/day. The maximum dose of Losartan will be 100 mg/day.

Trial Locations (1)

92801

ACRI- Phase 1, Anaheim

Sponsors

Lead Sponsor

Vifor Pharma
All Listed Sponsors
lead

Vifor Pharma

INDUSTRY